China Resources Sanjiu Medical & Pharmaceutical Co Ltd

SHE:000999 China Drug Manufacturers - Specialty & Generic
Market Cap
$6.69 Billion
CN¥49.06 Billion CNY
Market Cap Rank
#4425 Global
#451 in China
Share Price
CN¥29.48
Change (1 day)
+0.55%
52-Week Range
CN¥27.91 - CN¥45.53
All Time High
CN¥1328.34
Categories
Companies in China Drug Manufacturers - Specialty & Generic
About

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People's Republic of China and internationally. The company offers health consumer products (CHC), including cold, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug products,… Read more

China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) - Net Assets

Latest net assets as of September 2025: CN¥37.38 Billion CNY

Based on the latest financial reports, China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) has net assets worth CN¥37.38 Billion CNY as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥56.56 Billion) and total liabilities (CN¥19.18 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥37.38 Billion
% of Total Assets 66.08%
Annual Growth Rate 15.07%
5-Year Change 79.64%
10-Year Change 229.11%
Growth Volatility 47.4

China Resources Sanjiu Medical & Pharmaceutical Co Ltd - Net Assets Trend (1997–2024)

This chart illustrates how China Resources Sanjiu Medical & Pharmaceutical Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for China Resources Sanjiu Medical & Pharmaceutical Co Ltd (1997–2024)

The table below shows the annual net assets of China Resources Sanjiu Medical & Pharmaceutical Co Ltd from 1997 to 2024.

Year Net Assets Change
2024-12-31 CN¥25.26 Billion +4.10%
2023-12-31 CN¥24.26 Billion +38.38%
2022-12-31 CN¥17.53 Billion +11.59%
2021-12-31 CN¥15.71 Billion +11.76%
2020-12-31 CN¥14.06 Billion +9.14%
2019-12-31 CN¥12.88 Billion +15.34%
2018-12-31 CN¥11.17 Billion +10.31%
2017-12-31 CN¥10.12 Billion +16.09%
2016-12-31 CN¥8.72 Billion +13.65%
2015-12-31 CN¥7.67 Billion +9.70%
2014-12-31 CN¥7.00 Billion +9.97%
2013-12-31 CN¥6.36 Billion +14.08%
2012-12-31 CN¥5.58 Billion +14.96%
2011-12-31 CN¥4.85 Billion +8.67%
2010-12-31 CN¥4.46 Billion +12.96%
2009-12-31 CN¥3.95 Billion +15.79%
2008-12-31 CN¥3.41 Billion +18.35%
2007-12-31 CN¥2.88 Billion +13.29%
2006-12-31 CN¥2.55 Billion +6.39%
2005-12-31 CN¥2.39 Billion +4.57%
2004-12-31 CN¥2.29 Billion -26.05%
2003-12-31 CN¥3.09 Billion +6.61%
2002-12-31 CN¥2.90 Billion -1.70%
2001-12-31 CN¥2.95 Billion -0.94%
2000-12-31 CN¥2.98 Billion +12.31%
1999-12-31 CN¥2.65 Billion +255.19%
1998-12-31 CN¥747.10 Million +30.92%
1997-12-31 CN¥570.67 Million --

Equity Component Analysis

This analysis shows how different components contribute to China Resources Sanjiu Medical & Pharmaceutical Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 1612109317600.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CN¥16.12 Billion 81.00%
Common Stock CN¥1.28 Billion 6.45%
Other Components CN¥2.50 Billion 12.55%
Total Equity CN¥19.90 Billion 100.00%

China Resources Sanjiu Medical & Pharmaceutical Co Ltd Competitors by Market Cap

The table below lists competitors of China Resources Sanjiu Medical & Pharmaceutical Co Ltd ranked by their market capitalization.

Company Market Cap
NHK Spring Co. Ltd
F:NHK
 		$2.47 Billion
Toyo Tires & Rubber
F:TYR
 		$2.47 Billion
Jinan Shengquan Group Share Holding Co Ltd
SHG:605589
 		$2.47 Billion
Mineral Resources Limited
PINK:MALRF
 		$2.47 Billion
Freedom Holding Corp
NASDAQ:FRHC
 		$2.47 Billion
Engie Brasil Energia SA
PINK:EGIEY
 		$2.47 Billion
Dana Inc
NYSE:DAN
 		$2.46 Billion
First Capital Real Estate Investment Trust
PINK:FCXXF
 		$2.46 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in China Resources Sanjiu Medical & Pharmaceutical Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 18,967,141,875 to 19,903,111,306, a change of 935,969,431 (4.9%).
  • Net income of 3,367,888,969 contributed positively to equity growth.
  • Dividend payments of 2,834,425,365 reduced retained earnings.
  • Share repurchases of 2,208,928 reduced equity.
  • Other factors increased equity by 404,714,755.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥3.37 Billion +16.92%
Dividends Paid CN¥2.83 Billion -14.24%
Share Repurchases CN¥2.21 Million -0.01%
Other Changes CN¥404.71 Million +2.03%
Total Change CN¥- 4.93%

Book Value vs Market Value Analysis

This analysis compares China Resources Sanjiu Medical & Pharmaceutical Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.90x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 72.27x to 1.90x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1997-12-31 CN¥0.41 CN¥29.48 x
1998-12-31 CN¥0.55 CN¥29.48 x
1999-12-31 CN¥2.02 CN¥29.48 x
2000-12-31 CN¥2.03 CN¥29.48 x
2001-12-31 CN¥2.05 CN¥29.48 x
2002-12-31 CN¥2.12 CN¥29.48 x
2003-12-31 CN¥2.29 CN¥29.48 x
2004-12-31 CN¥1.66 CN¥29.48 x
2005-12-31 CN¥1.75 CN¥29.48 x
2006-12-31 CN¥1.88 CN¥29.48 x
2007-12-31 CN¥2.08 CN¥29.48 x
2008-12-31 CN¥2.52 CN¥29.48 x
2009-12-31 CN¥2.88 CN¥29.48 x
2010-12-31 CN¥3.30 CN¥29.48 x
2011-12-31 CN¥3.59 CN¥29.48 x
2012-12-31 CN¥4.16 CN¥29.48 x
2013-12-31 CN¥4.82 CN¥29.48 x
2014-12-31 CN¥5.32 CN¥29.48 x
2015-12-31 CN¥5.97 CN¥29.48 x
2016-12-31 CN¥6.75 CN¥29.48 x
2017-12-31 CN¥7.73 CN¥29.48 x
2018-12-31 CN¥8.49 CN¥29.48 x
2019-12-31 CN¥9.87 CN¥29.48 x
2020-12-31 CN¥10.79 CN¥29.48 x
2021-12-31 CN¥12.01 CN¥29.48 x
2022-12-31 CN¥13.37 CN¥29.48 x
2023-12-31 CN¥14.83 CN¥29.48 x
2024-12-31 CN¥15.54 CN¥29.48 x

Capital Efficiency Dashboard

This dashboard shows how efficiently China Resources Sanjiu Medical & Pharmaceutical Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 16.92%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 12.20%
  • • Asset Turnover: 0.69x
  • • Equity Multiplier: 2.01x
  • Recent ROE (16.92%) is above the historical average (11.86%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1997 19.03% 8.90% 0.76x 2.83x CN¥46.89 Million
1998 21.71% 10.58% 0.84x 2.46x CN¥81.35 Million
1999 8.55% 14.92% 0.41x 1.39x CN¥-37.37 Million
2000 7.81% 11.03% 0.31x 2.28x CN¥-56.67 Million
2001 4.65% 6.48% 0.28x 2.53x CN¥-139.36 Million
2002 6.11% 7.62% 0.32x 2.54x CN¥-104.87 Million
2003 7.18% 7.81% 0.32x 2.85x CN¥-82.14 Million
2004 -34.10% -29.28% 0.34x 3.40x CN¥-932.18 Million
2005 5.37% 4.04% 0.42x 3.15x CN¥-103.34 Million
2006 6.88% 5.75% 0.41x 2.94x CN¥-74.76 Million
2007 10.25% 8.23% 0.44x 2.85x CN¥6.82 Million
2008 15.63% 11.59% 0.85x 1.58x CN¥180.08 Million
2009 19.25% 14.62% 0.86x 1.53x CN¥340.86 Million
2010 19.37% 18.69% 0.72x 1.45x CN¥394.69 Million
2011 16.73% 13.76% 0.73x 1.67x CN¥305.95 Million
2012 19.23% 14.71% 0.81x 1.62x CN¥490.11 Million
2013 18.03% 15.20% 0.71x 1.67x CN¥493.91 Million
2014 15.32% 14.24% 0.68x 1.58x CN¥359.89 Million
2015 16.50% 15.81% 0.66x 1.59x CN¥492.06 Million
2016 13.90% 13.34% 0.66x 1.57x CN¥336.34 Million
2017 13.23% 11.71% 0.69x 1.65x CN¥317.84 Million
2018 13.23% 10.67% 0.74x 1.67x CN¥349.31 Million
2019 16.71% 14.19% 0.74x 1.60x CN¥842.46 Million
2020 11.64% 11.71% 0.62x 1.60x CN¥224.78 Million
2021 13.45% 13.22% 0.64x 1.59x CN¥526.85 Million
2022 14.40% 13.54% 0.67x 1.59x CN¥747.84 Million
2023 15.04% 11.53% 0.62x 2.12x CN¥956.22 Million
2024 16.92% 12.20% 0.69x 2.01x CN¥1.38 Billion

Industry Comparison

This section compares China Resources Sanjiu Medical & Pharmaceutical Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $2,123,990,643
  • Average return on equity (ROE) among peers: -0.22%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) CN¥37.38 Billion 19.03% 0.51x $2.47 Billion
Shenzhen Neptunus Bioengineering Co Ltd (000078) $6.47 Billion 9.88% 3.77x $616.08 Million
Anhui Fengyuan Pharmaceutical Co Ltd (000153) $1.18 Billion 2.74% 0.95x $320.56 Million
Shan Dong Dong-E E-Jiao Co Ltd (000423) $10.33 Billion 15.07% 0.27x $3.03 Billion
Wedge Industrial Co Ltd (000534) $298.72 Million 1.96% 0.38x $1.77 Billion
Yunnan Baiyao Group Co Ltd (000538) $35.11 Million 18.13% 0.80x $5.62 Billion
Hainan Haiyao Co Ltd (000566) $353.98 Million -9.58% 0.80x $702.18 Million
Tus Pharmaceutical Group Co Ltd (000590) $269.51 Million -61.02% 1.05x $317.08 Million
Northeast Pharmaceutical Group Co Ltd (000597) $927.49 Million 2.65% 1.38x $425.60 Million
Jilin Aodong Pharmaceutical Group Co Ltd (000623) $1.11 Billion 7.32% 0.29x $2.05 Billion
Renhe Pharmacy Co Ltd (000650) $261.49 Million 10.60% 0.82x $777.45 Million